Pilot study on cannabis-induced alterations in platelet function: implications for transfusion medicine

✦ New
CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications.
⚒ Cannabis News  |  CED Clinic
SurgeryBleeding RiskPerioperative CareDrug InteractionsPlatelet Function
Why This Matters

Platelet function alterations could impact surgical bleeding risk and transfusion protocols for cannabis patients. This represents the first systematic examination of cannabis effects on hemostasis, addressing a critical gap in perioperative cannabis guidance.

Clinical Summary

This pilot study investigated cannabis-induced changes in platelet aggregation and function in healthy volunteers. Preliminary findings suggest acute cannabis use may alter platelet aggregation patterns, though the clinical significance and duration of these effects remain unclear. The study provides initial mechanistic insights into potential cannabis-coagulation interactions, but sample sizes were limited and effects were measured only acutely post-consumption.

Dr. Caplan’s Take

“We’ve been flying blind on cannabis and bleeding risk for years โ€” this gives us our first real data points. Until we have larger studies with clinical endpoints, I’m advising patients to disclose cannabis use before any procedure and discussing timing with their surgical teams.”

Clinical Perspective
🧠 Clinicians should specifically ask about cannabis use during pre-procedural assessments and consider timing of last use. Patients should be counseled to disclose cannabis consumption to their care teams, particularly before surgeries or procedures. More research is needed before definitive perioperative cannabis guidelines can be established.

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

FAQ

What are the main surgical risks associated with cannabis use?

Cannabis use can increase bleeding risk during surgery due to its effects on platelet function and blood coagulation. Patients who use cannabis may also experience complications with anesthesia and altered pain perception during the perioperative period.

How long before surgery should patients stop using cannabis?

Patients should typically discontinue cannabis use at least 1-2 weeks before elective surgery to minimize bleeding and anesthetic complications. The exact timing may vary based on the frequency of use and type of surgical procedure planned.

Can cannabis interact with medications used during surgery?

Yes, cannabis can interact with various perioperative medications including anesthetics, pain medications, and anticoagulants. These interactions can affect drug metabolism and increase the risk of adverse effects during and after surgery.

Should patients tell their surgeon about cannabis use?

Absolutely, patients must inform their surgical team about all cannabis use, including frequency and timing of last use. This information is critical for proper perioperative planning and risk management to ensure patient safety.

What are the specific bleeding concerns with cannabis and surgery?

Cannabis can affect blood clotting mechanisms and may interact with anticoagulant medications used during surgery. This can lead to increased bleeding during the procedure and potentially delayed healing in the postoperative period.






{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Pilot study on cannabis-induced alterations in platelet function: implications for transfusion medicine”, “url”: “https://www.tandfonline.com/doi/abs/10.1080/09537104.2026.2644368”, “datePublished”: “2026-03-28T17:56:48Z”, “about”: “pilot study cannabis induced alterations platelet”}